MESSAGE

Section NCT
Category Skin tumors
Subcategory Melanoma
Trial Type Other clinical trials
Description for experts Survivorship in Melanoma Cross-sectional study to assess quality oflife, health-status and needs of stage III Melanoma survivors (in an extended/permanent survival period) In Germany
Description for laymen
JSON Data { "short_title": "MESSAGE", "data_mode": "900", "data_mode_number": "000002281", "official_title": "Belastungen & Bed\u00fcrfnisse von Melanom Survivors", "accrual_state": "running", "therapeutic_value": "nonTherapeutic", "therapieansatz_value": null, "therapieintervention_value": null, "therapielinie_value": null, "ctgov_number": null, "eudract_number": null, "general_contact_email": null, "general_contact_phone": null, "hauptpruefer_dd_name": "Prof. Dr. med. Friedegund Meier", "description_laie_de": "Lebensqualit\u00e4t und zielgruppengerechte Angebote von und f\u00fcr Survivors nach vorbeugender (adjuvanter) Therapie", "description_laie_en": null, "description_expert_de": null, "description_expert_en": "Survivorship in Melanoma Cross-sectional study to assess quality oflife, health-status and needs of stage III Melanoma survivors (in an extended/permanent survival period) In Germany", "rechtsgrundlage_value": "AMG", "phase_amg_value": "N/A", "main_cat_id": 5, "sub_cat_id": 35 }
Settings
Short name 900-000002281